Cargando…
Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration
Associations of modulators of quality of life (QoL) and survival duration are assessed in the fatal motor neuron disease, Amyotrophic Lateral Sclerosis. Major categories include clinical impression of mood (CIM); physical health; patient social support; and usage of interventions, pharmaceuticals, a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016647/ https://www.ncbi.nlm.nih.gov/pubmed/31936812 http://dx.doi.org/10.3390/bs10010033 |
_version_ | 1783497023111036928 |
---|---|
author | Bond, Leila Bowen, Gloria Mertens, Benjamin Denson, Keelie Jordan, Kathleen Vidakovic, Branislav Mitchell, Cassie S. |
author_facet | Bond, Leila Bowen, Gloria Mertens, Benjamin Denson, Keelie Jordan, Kathleen Vidakovic, Branislav Mitchell, Cassie S. |
author_sort | Bond, Leila |
collection | PubMed |
description | Associations of modulators of quality of life (QoL) and survival duration are assessed in the fatal motor neuron disease, Amyotrophic Lateral Sclerosis. Major categories include clinical impression of mood (CIM); physical health; patient social support; and usage of interventions, pharmaceuticals, and supplements. Associations were assessed at p < 0.05 and p < 0.001 significance thresholds using applicable methods (Chi-square, t-test, ANOVA, logistical regression, random forests, Fisher’s exact test) within a retrospective cohort of 1585 patients. Factors significantly correlated with positive (happy or normal) mood included family support and usage of bi-level positive airway pressure (Bi-PAP) and/or cough assist. Decline in physical factors like presence of dysphagia, drooling, general pain, and decrease in ALSFRS-R total score or forced vital capacity (FVC) significantly correlated with negative (depressed or anxious) mood (p < 0.05). Use of antidepressants or pain medications had no association with ALS patient mood (p > 0.05), but were significantly associated with increased survival (p < 0.05). Positive patient mood, Bi-PAP, cough assist, percutaneous endoscopic gastrostomy (PEG), and accompaniment to clinic visits associated with increased survival duration (p < 0.001). Of the 47 most prevalent pharmaceutical and supplement categories, 17 associated with significant survival duration increases ranging +4.5 to +16.5 months. Tricyclic antidepressants, non-opioids, muscle relaxants, and vitamin E had the highest associative increases in survival duration (p < 0.05). Random forests, which examined complex interactions, identified the following pharmaceuticals and supplements as most predictive to survival duration: Vitamin A, multivitamin, PEG supplements, alternative herbs, antihistamines, muscle relaxants, stimulant laxatives, and antispastics. Statins, metformin, and thiazide diuretics had insignificant associations with decreased survival. |
format | Online Article Text |
id | pubmed-7016647 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70166472020-03-04 Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration Bond, Leila Bowen, Gloria Mertens, Benjamin Denson, Keelie Jordan, Kathleen Vidakovic, Branislav Mitchell, Cassie S. Behav Sci (Basel) Article Associations of modulators of quality of life (QoL) and survival duration are assessed in the fatal motor neuron disease, Amyotrophic Lateral Sclerosis. Major categories include clinical impression of mood (CIM); physical health; patient social support; and usage of interventions, pharmaceuticals, and supplements. Associations were assessed at p < 0.05 and p < 0.001 significance thresholds using applicable methods (Chi-square, t-test, ANOVA, logistical regression, random forests, Fisher’s exact test) within a retrospective cohort of 1585 patients. Factors significantly correlated with positive (happy or normal) mood included family support and usage of bi-level positive airway pressure (Bi-PAP) and/or cough assist. Decline in physical factors like presence of dysphagia, drooling, general pain, and decrease in ALSFRS-R total score or forced vital capacity (FVC) significantly correlated with negative (depressed or anxious) mood (p < 0.05). Use of antidepressants or pain medications had no association with ALS patient mood (p > 0.05), but were significantly associated with increased survival (p < 0.05). Positive patient mood, Bi-PAP, cough assist, percutaneous endoscopic gastrostomy (PEG), and accompaniment to clinic visits associated with increased survival duration (p < 0.001). Of the 47 most prevalent pharmaceutical and supplement categories, 17 associated with significant survival duration increases ranging +4.5 to +16.5 months. Tricyclic antidepressants, non-opioids, muscle relaxants, and vitamin E had the highest associative increases in survival duration (p < 0.05). Random forests, which examined complex interactions, identified the following pharmaceuticals and supplements as most predictive to survival duration: Vitamin A, multivitamin, PEG supplements, alternative herbs, antihistamines, muscle relaxants, stimulant laxatives, and antispastics. Statins, metformin, and thiazide diuretics had insignificant associations with decreased survival. MDPI 2020-01-10 /pmc/articles/PMC7016647/ /pubmed/31936812 http://dx.doi.org/10.3390/bs10010033 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bond, Leila Bowen, Gloria Mertens, Benjamin Denson, Keelie Jordan, Kathleen Vidakovic, Branislav Mitchell, Cassie S. Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration |
title | Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration |
title_full | Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration |
title_fullStr | Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration |
title_full_unstemmed | Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration |
title_short | Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration |
title_sort | associations of patient mood, modulators of quality of life, and pharmaceuticals with amyotrophic lateral sclerosis survival duration |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016647/ https://www.ncbi.nlm.nih.gov/pubmed/31936812 http://dx.doi.org/10.3390/bs10010033 |
work_keys_str_mv | AT bondleila associationsofpatientmoodmodulatorsofqualityoflifeandpharmaceuticalswithamyotrophiclateralsclerosissurvivalduration AT bowengloria associationsofpatientmoodmodulatorsofqualityoflifeandpharmaceuticalswithamyotrophiclateralsclerosissurvivalduration AT mertensbenjamin associationsofpatientmoodmodulatorsofqualityoflifeandpharmaceuticalswithamyotrophiclateralsclerosissurvivalduration AT densonkeelie associationsofpatientmoodmodulatorsofqualityoflifeandpharmaceuticalswithamyotrophiclateralsclerosissurvivalduration AT jordankathleen associationsofpatientmoodmodulatorsofqualityoflifeandpharmaceuticalswithamyotrophiclateralsclerosissurvivalduration AT vidakovicbranislav associationsofpatientmoodmodulatorsofqualityoflifeandpharmaceuticalswithamyotrophiclateralsclerosissurvivalduration AT mitchellcassies associationsofpatientmoodmodulatorsofqualityoflifeandpharmaceuticalswithamyotrophiclateralsclerosissurvivalduration |